Total Funding
23
Total FundingSeed raised
Growth Score
pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
257959
Helio Vision develops a therapy for rare, fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery.
Dean Eliott: Chairman & Co-Founder
Mike Aceti: CFO
About the Company
Helio Vision was founded in 2016 to develop a therapy for rare, fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery.
The co-founders of Helio Vision, Massachusetts Eye and Ear Infirmary physicians Drs. Dean Eliott and Tomasz Stryjewski, have discovered that by using sustained intravitreal exposure to
methotrexate, a medication with anti-proliferative and anti-inflammatory properties, this dreaded post-operative scarring cycle may be prevented.
